Cite
MLA Citation
Giulio Metro et al.. “Optimal management of ALK-positive NSCLC progressing on crizotinib.” Lung cancer, vol. 106, 2017, pp. 58–66. http://access.bl.uk/ark:/81055/vdc_100045084215.0x000032
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Giulio Metro et al.. “Optimal management of ALK-positive NSCLC progressing on crizotinib.” Lung cancer, vol. 106, 2017, pp. 58–66. http://access.bl.uk/ark:/81055/vdc_100045084215.0x000032